Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era

Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era

BackgroundElderly patients diagnosed with diffuse large B-cell lymphoma (DLBCL) undergoing reduced intensity R-CHOP therapy are at a heightened risk of acquiring infections, notably coronavirus disease 2019 (COVID-19) infection. This study aimed to evaluate the efficacy of intravenous immunoglobulin...

Full description

Bibliographic Details
Main Authors: Dong Won Baek, Ga-Young Song, Ho Sup Lee, Young Rok Do, Ji Hyun Lee, Ho-Young Yhim, Joon Ho Moon, Deok-Hwan Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Oncology
Subjects:
COVID-19
diffuse large B-cell lymphoma
elderly
hypogammaglobulinemia
immunochemotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1380492/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1380492/full

Similar Items